Ondonsetron is a potent
## **Core Concept**
Ondansetron is a medication primarily used to prevent nausea and vomiting caused by cancer chemotherapy, radiation therapy, and surgery. It belongs to a class of drugs known as **5-HT3 receptor antagonists**. These drugs work by blocking the action of serotonin, a natural substance that may cause nausea and vomiting.
## **Why the Correct Answer is Right**
The correct answer, **5-HT3 receptor antagonist**, is right because ondansetron exerts its antiemetic effects by selectively binding to and blocking the **5-hydroxytryptamine3 (5-HT3)** receptors. These receptors are found centrally in the **chemoreceptor trigger zone** of the area postrema and peripherally on the vagus nerve and enteric neurons of the gastrointestinal tract. By blocking these receptors, ondansetron prevents the initiation of the vomiting reflex.
## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is incorrect because ondansetron does not primarily act as a dopamine antagonist. While dopamine antagonists can also have antiemetic effects (e.g., metoclopramide), ondansetron's mechanism is distinct and involves serotonin receptors.
- **Option B:** This option is incorrect as there is no commonly recognized class of antiemetics referred to by this description in relation to ondansetron's mechanism.
- **Option C:** This option is incorrect because ondansetron is not a corticosteroid. Corticosteroids do have anti-inflammatory properties and can be used in some cases to enhance the effects of other antiemetics but are not 5-HT3 receptor antagonists.
## **Clinical Pearl / High-Yield Fact**
A key point to remember is that **5-HT3 receptor antagonists like ondansetron** are particularly effective in controlling acute nausea and vomiting associated with chemotherapy and are often used in combination with other antiemetics for enhanced effect. A classic clinical scenario where ondansetron shines is in the prevention of chemotherapy-induced nausea and vomiting.
## **Correct Answer:** D. 5-HT3 receptor antagonist.